bioRxiv ScienceSearch

bioRxiv · 10.1101/341719

Predicting the effects of epidural stimulation to improve hand function in patients with spinal cord injury: An active learning-based solution using dynamic sample weighting

Abstract

In patients with chronic spinal cord injury (SCI), few therapies are available to improve neurological function. Neuromodulation of the spinal cord with epidural stimulation (EDS) has shown promise enabling the voluntary activation of motor pools caudal to the level of the injury. EDS is performed with multiple electrode arrays in which several stimulation variables such as the frequency, amplitude, and location of the stimulation significantly affect the type and amplitude of motor responses. This paper presents a novel technique to predict the final functionality of a patient with SCI after cervical EDS within a deep learning framework. Additionally, we suggest a committee-based active learning method to reduce the number of clinical experiments required to optimize EDS stimulation variables by exploring the stimulation configuration space more efficiently. We also developed a novel method to dynamically weight the results of different experiments using neural networks to create an optimal estimate of the quantity of interest. The essence of our approach was to use machine learning methods to predict the hand contraction force in a patient with chronic SCI based on different EDS parameters. The accuracy of the prediction of stimulation outcomes was evaluated based on three measurements: mean absolute error, standard deviation, and correlation coefficient. The results show that the proposed method can be used to reliably predict the outcome of cervical EDS on maximum voluntary contraction force of the hand with a prediction error of approximately 15%. This model could allow scientists to establish stimulation parameters more efficiently for SCI patients to produce enhanced motor responses in this novel application.\n\nAuthor SummarySpinal cord injury (SCI) can lead to permanent sensorimotor deficits that have a major impact on quality of life. In patients with a motor complete injury, there is no therapy available to reliably improve motor function. Recently, neuromodulation of the spinal cord with epidural stimulation (EDS) has allowed patients with motor-complete SCI regain voluntary movement below the level of injury in the cervical and thoracic spine. EDS is performed using multi-electrode arrays placed in the dorsal epidural space spanning several spinal segments. There are numerous stimulation parameters that can be modified to produce different effects on motor function. Previously, defining these parameters was based on observation and empiric testing, which are time-consuming and inefficient processes. There is a need for an automated method to predict motor and sensory function based on a given combination of EDS settings. We developed a novel method to predict the gripping function of a patient with SCI undergoing cervical EDS based on a set of stimulation parameters within a deep learning framework. We also addressed a limiting factor in machine learning methods in EDS, which is a general lack of training measurements for the learning model. We proposed a novel active learning method to minimize the number of training measurements required. The model for predicting responses to EDS could be used by scientists and clinicians to efficiently determine a set of stimulation parameters that produce a desired effect on motor function.

Explore related subjects

Keep this discovery

BibTeXRIS

Kachuee, M., Hoffman, H., Moore, L. D., Damavandi, H. G., Homsey, T., Moatamed, B., Hosseini, A., Huang, R., Leiter, J. C., Sarrafzadeh, M., Lu, D. C.. 2018-06-07. Predicting the effects of epidural stimulation to improve hand function in patients with spinal cord injury: An active learning-based solution using dynamic sample weighting. https://doi.org/10.1101/341719

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience